Literature DB >> 10383750

A premature stop codon mutation in the 2B helix termination peptide of keratin 5 in a German epidermolysis bullosa simplex Dowling-Meara case.

F B Müller1, I Anton-Lamprecht, W Küster, B P Korge.   

Abstract

Epidermolysis bullosa simplex (EBS) is caused by defective assembly of keratin intermediate filaments in basal keratinocytes and recent studies indicated causal mutations in the keratin KRT5 and KRT14 genes. In this study, we describe a novel KRT5 mutation in a German sporadic case of EBS Dowling-Meara. Transition of G to T (nucleotide position 2334) leads to a premature stop codon (E477stop, residue 93 of the 2B helix) in the last residue of the highly conserved helix-termination peptide K/LLEGE of the 2B rod domain of keratin K5. This represents the first premature stop codon mutation identified within the K/LLEGE motif of any disorder reported so far that is caused by keratin mutations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383750     DOI: 10.1046/j.1523-1747.1999.00615.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  3 in total

Review 1.  Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise.

Authors:  Jean Christopher Chamcheu; Gary S Wood; Imtiaz A Siddiqui; Deeba N Syed; Vaqar M Adhami; Joyce M Teng; Hasan Mukhtar
Journal:  Exp Dermatol       Date:  2012-07       Impact factor: 3.960

2.  Defining the properties of the nonhelical tail domain in type II keratin 5: insight from a bullous disease-causing mutation.

Authors:  Li-Hong Gu; Pierre A Coulombe
Journal:  Mol Biol Cell       Date:  2005-01-12       Impact factor: 4.138

3.  Occurrence of autoantibodies against skin proteins in patients with hereditary epidermolysis bullosa predisposes to development of autoimmune blistering disease.

Authors:  Saskia Lehr; Felicitas Felber; Iliana Tantcheva-Poór; Christina Keßler; Rüdiger Eming; Alexander Nyström; Marta Rizzi; Dimitra Kiritsi
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.